Quantcast
Last updated on April 23, 2014 at 20:10 EDT

Latest Dendreon Stories

2013-02-25 08:29:05

NEW YORK, February 25, 2013 /PRNewswire/ -- Today, National Traders Association announced new research reports highlighting Medivation, Inc. (NASDAQ: MDVN), Dendreon Corporation (NASDAQ: DNDN), True Religion Apparel, Inc. (NASDAQ: TRLG), V.F. Corporation (NYSE: VFC) and Electronic Arts Inc. (NASDQ: EA). Today's readers may access these reports free of charge - including full price targets, industry analysis and analyst ratings - via the links below. Medivation, Inc....

2013-01-15 08:25:07

HONG KONG, Jan. 15, 2013 /PRNewswire/ -- Pennystocksinsiders.com (PSI) has issued insider trading reports and equity research for the following companies: Dendreon (NASDAQ:DNDN), QUALCOMM (NASDAQ:QCOM), Transocean (NYSE:RIG), United Parcel Service (NYSE:UPS), Vale SA (NYSE:VALE), and Groupon (NASDAQ:GRPN). (Logo: http://photos.prnewswire.com/prnh/20121105/HK06856LOGO ) (Read the full report by clicking the link below, you may need to copy and paste the full link to your browser.)...

2013-01-14 12:25:11

LONDON, January 14, 2013 /PRNewswire/ -- Although much has been made over pharmaceutical company profits tumbling due to loss of exclusivity for blockbuster drugs, companies in the biotechnology technology industry have been turning in strong quarterly earnings, and also have a number of exciting new products that are scheduled to soon hit the market. Companies like Dendreon Corporation (NASDAQ:DNDN), Sequenom Inc. (NASDAQ:SQNM) and Celgene Corporation (NASDAQ:CELG) have been...

2012-08-01 02:32:32

VANCOUVER, British Columbia, Aug. 1, 2012 /PRNewswire-Asia/ -- Insiderslab.com has issued insider trading reports and Equity Research for the following companies: Pfizer (NYSE:PFE), Dendreon (NASDAQ:DNDN), Frontier (NASDAQ:FTR), BP (NYSE:BP), Allergan (NYSE:AGN), and Herbalife (NYSE:HLF). (Logo: http://photos.prnewswire.com/prnh/20100419/HKM001LOGO ) (Read full report by clicking the link below, you may need to copy and paste the full link to your browser.) Report Highlights: Pfizer...

2012-07-31 10:25:28

LAKE FOREST, Ill., July 31, 2012 /PRNewswire/ -- Hospira, Inc. (NYSE: HSP), the world's leading provider of injectable drugs and infusion technologies, today announced that Dennis M. Fenton, Ph.D., has been elected to the company's board of directors. Dr. Fenton, a recognized manufacturing and biologics expert, has more than 30 years of healthcare industry experience. The addition of Dr. Fenton expands Hospira's board to 11 directors, 10 of whom are independent. "We are excited to welcome...

2012-06-20 02:27:25

WORCESTER, Mass. and TORONTO, June 20, 2012 /PRNewswire/ -- Generex Biotechnology Corporation (OTCBB:GNBT) announced today the results of the Company's annual meeting of stockholders held on June 19, 2012. At the annual meeting of stockholders, the following directors were elected to serve on the Board of Directors until the next annual meeting of stockholders: John Barratt, Brian McGee, Nola Masterson, Mark Fletcher, Dr. James H. Anderson, Jr., MD, and Dr. Eric Von Hofe,...

2012-06-19 02:26:32

SAN DIEGO, June 19, 2012 /PRNewswire/ -- Althea Technologies, a leading provider of development and manufacturing services for biopharmaceutical products, today announced that Dennis Fenton, Ph.D., will chair Althea's Scientific Advisory Board and be appointed as Board Observer. Dr. Fenton brings 35 years of experience in the biotechnology and pharmaceutical industries to this role. Starting his career at Pfizer Central Research, he subsequently joined Amgen at its inception, where during...

2012-06-14 02:29:45

VANCOUVER, British Columbia, June 14, 2012 /PRNewswire-Asia/ -- Pennystocksinsiders.com (PSI) has issued insider trading reports and Equity Research for the following companies: Dendreon (NASDAQ:DNDN), Comcast (NASDAQ:CMCSA), Goldcorp (NYSE:GG), Alcoa (NYSE:AA), United Technologies (NYSE:UTX), and Peabody Energy (NYSE:BTU). (Logo: http://photos.prnewswire.com/prnh/20120531/HK16417LOGO) (Read full report by clicking the link below, you may need to copy and paste the full link to your...

2012-06-07 02:28:56

WORCESTER, Mass. and TORONTO, June 7, 2012 /PRNewswire/ -- Generex Biotechnology Corporation (OTCBB: GNBT.OB) announced today that an End-of-Phase II meeting has been scheduled with the United States Food and Drug Administration (FDA) in respect of the Phase II clinical trial of the AE37 breast cancer vaccine being undertaken by its wholly-owned subsidiary, Antigen Express, Inc. The meeting has been scheduled for June 18, 2012 with FDA regulatory management staff in the Office of Cellular...

2012-05-22 10:23:12

LOS ANGELES, May 22, 2012 /PRNewswire/ -- Genesis Biopharma, Inc. (OTC/BB: GNBP), a biotechnology company developing targeted cancer immunotherapies, was mentioned favorably in an article in BioMedReports that was issued earlier today. The article can be accessed at the following link: http://www.biomedreports.com/2012052295011/darling-dendreon-continues-taking-huge-hits.html About Genesis Biopharma, Inc. Genesis Biopharma, Inc. is engaged in the development and commercialization of...